François Bertucci Selected Research

François Bertucci Research Topics

Disease

133	Neoplasms (Cancer) 11/2022 - 10/2002
98	Breast Neoplasms (Breast Cancer) 11/2022 - 04/2002
26	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 01/2012
22	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2002
20	Inflammatory Breast Neoplasms 10/2021 - 12/2004
11	Triple Negative Breast Neoplasms 06/2022 - 05/2013
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2022 - 02/2011
6	Adenocarcinoma 01/2022 - 11/2006
6	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 06/2008
5	Leiomyosarcoma 01/2022 - 11/2014
5	Neutropenia 01/2022 - 03/2015
5	Carcinogenesis 10/2021 - 03/2011
5	Disease Progression 01/2021 - 09/2011
5	Hypertension (High Blood Pressure) 01/2021 - 01/2016
5	Carcinoma (Carcinomatosis) 07/2020 - 07/2003
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2010
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 02/2004
4	Asthenia 12/2021 - 12/2016
4	Aggressive Fibromatosis (Desmoid) 01/2021 - 01/2013
4	Hemangiosarcoma (Angiosarcoma) 10/2018 - 07/2012
3	Circulating Neoplastic Cells 02/2022 - 06/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2014
3	Thrombocytopenia (Thrombopenia) 01/2022 - 04/2015
3	Liposarcoma 10/2020 - 12/2016
3	Melanoma (Melanoma, Malignant) 07/2019 - 09/2007
3	Synovial Sarcoma (Synovioma) 01/2018 - 05/2013
3	Chordoma 01/2017 - 10/2011
2	Febrile Neutropenia 01/2022 - 04/2015
2	Pain (Aches) 01/2021 - 01/2017
2	Margins of Excision 06/2020 - 10/2018
2	Phyllodes Tumor (Cystosarcoma Phylloides) 06/2020 - 05/2020
2	Genomic Instability 01/2019 - 12/2018
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2005

Drug/Important Bio-Agent (IBA)

41	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 07/2002
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
22	Messenger RNA (mRNA)IBA 07/2021 - 05/2002
17	Phenobarbital (Luminal)FDA Link 05/2021 - 08/2004
16	Biomarkers (Surrogate Marker)IBA 09/2021 - 03/2003
14	Hormones (Hormone)IBA 11/2022 - 10/2007
11	Imatinib Mesylate (Gleevec)FDA Link 03/2022 - 02/2010
10	AnthracyclinesIBA 06/2021 - 04/2002
10	Biological ProductsIBA 01/2021 - 11/2005
8	Immune Checkpoint InhibitorsIBA 03/2022 - 08/2017
8	TrabectedinIBA 01/2022 - 02/2013
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 04/2012
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2012
7	Estrogen ReceptorsIBA 07/2021 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2007
6	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2012
6	Trastuzumab (Herceptin)FDA Link 06/2020 - 12/2014
6	Bevacizumab (Avastin)FDA Link 05/2019 - 09/2015
6	LigandsIBA 03/2018 - 11/2011
5	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2002
5	human ERBB2 proteinIBA 07/2021 - 01/2018
5	regorafenibIBA 01/2021 - 12/2016
5	Complementary DNA (cDNA)IBA 10/2002 - 04/2002
4	Progesterone Receptors (Progesterone Receptor)IBA 07/2021 - 05/2013
4	pazopanib FDA Link 01/2021 - 01/2016
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2020 - 05/2011
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2020 - 08/2012
4	Monoclonal AntibodiesIBA 01/2020 - 06/2008
4	Taxoids (Taxanes)IBA 10/2018 - 09/2011
4	ErbB Receptors (EGF Receptor)IBA 01/2017 - 06/2008
4	Phosphotransferases (Kinase)IBA 07/2011 - 02/2008
3	CytokinesIBA 03/2022 - 05/2002
3	CateninsIBA 01/2021 - 01/2018
3	Carboplatin (JM8)FDA LinkGeneric 05/2020 - 01/2018
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2020 - 01/2014
3	AntibodiesIBA 03/2020 - 01/2009
3	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2019 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2015
3	Docetaxel (Taxotere)FDA Link 04/2012 - 11/2009
2	TOR Serine-Threonine KinasesIBA 01/2022 - 11/2017
2	Antisense OligonucleotidesIBA 01/2022 - 07/2021
2	EnzymesIBA 01/2022 - 07/2012
2	amitraz (Taktic)IBA 01/2022 - 12/2021
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2022 - 12/2021
2	taxaneIBA 01/2022 - 03/2011
2	Peptides (Polypeptides)IBA 01/2021 - 01/2016
2	erdafitinibIBA 12/2020 - 10/2020
2	AntigensIBA 11/2020 - 03/2020
2	Lapatinib (GW572016)FDA Link 06/2020 - 11/2017
2	olaparibIBA 05/2020 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 04/2020 - 04/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2002
2	Transaminases (Aminotransferases)IBA 01/2020 - 11/2017
2	Cetuximab (Erbitux)FDA Link 12/2019 - 06/2008
2	MicroRNAs (MicroRNA)IBA 06/2019 - 10/2015
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 05/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2016

Therapy/Procedure

50	Therapeutics 05/2022 - 05/2002
41	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
12	Adjuvant Chemotherapy 09/2021 - 04/2002
9	Neoadjuvant Therapy 11/2022 - 11/2009
9	Precision Medicine 05/2022 - 03/2012
6	Radiotherapy 06/2020 - 11/2010
5	Immunotherapy 05/2021 - 01/2017
3	Stem Cell Transplantation 04/2017 - 01/2016
2	Castration 01/2022 - 12/2014
2	Laparotomy 05/2019 - 01/2012